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Abstract
Background: A major DHF outbreak occurred in Delhi in 1996. Following this another outbreak
was reported in the year 2003. In the years 2004 and 2005, though no outbreak was reported, a
definitely higher number of samples were received in the virology laboratory of A.I.I.M.S. from
suspected cases of dengue infection. This study was designed to compare the serological and
virological profiles of confirmed dengue cases in the years 2003, 2004 and 2005.
Results: Out of 1820 serum samples received from suspected cases in all three years, 811 (44.56%)
were confirmed as dengue infection serologically. Out of these confirmed dengue cases maximum
cases, in all three years, were seen in the age group 21–30 years. There was an increase in the
number of samples received in the post monsoon period (September to November) with a peak
in the second and third week of October. More samples were received from DHF cases in the year
2005 than 2004 and 2003. All four dengue serotypes were seen co-circulating in the year 2003,
followed by complete predominance of dengue serotype 3 in 2005.
Conclusion: Epidemiology of dengue is changing rapidly in Delhi. Dengue infections are seen every
year thus making it an endemic disease. After co-circulation of all serotypes in 2003, now dengue
serotype 3 is emerging as the predominant serotype.
Background
The global epidemiology of dengue fever/dengue hemor-
rhagic fever (DF/DHF) is changing fast [1]. The Indian
encounter with this disease is interesting and intriguing.
Dengue infection has been known to be endemic in India
for over two centuries as a benign and self limited disease.
In recent years, the disease has changed its course mani-
festing in the severe form as DHF and with increasing fre-
quency of outbreaks. Delhi, a city in North India, has
experienced seven outbreaks of dengue virus infection
since 1967 with the last reported in 2003 [2-4]. The 1996
epidemic in India was mainly due to the virus dengue -
2[2]. While in 2003 all four serotypes of dengue viruses
were found in co-circulation [5]. In the following years
2004 and 2005, though, outbreaks did not occur but
higher number of cases of suspected dengue infection
were reported to our hospital in the similar months as that
in 1996 and 2003. In this study we have compared the
serological and virological profiles of the confirmed den-
gue cases reported to All India Institute of Medical Sci-
ences (AIIMS) in these three years i.e. 2003, 2004, and
2005.
Results
During the study period (2003–2005), a total of 1820
serum samples were tested for dengue IgM antibodies,
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year wise distribution of the samples being 874 in 2003,
340 in 2004 & 606 in the year 2005. Of these 811
(44.56%) were positive for dengue specific IgM antibod-
ies. Year-wise distribution of dengue IgM positive cases
over 3 year period is shown in Table 1. Maximum num-
bers of samples were received in the year 2003. Out of
1820 samples received 868 were from indoor patients
with overall mortality of 4.14% in these indoor patients
only. Year wise mortality rates in indoor patients were
4.17% in 2003, 4.9% in 2004 and 3.6%, in 2005 (not
showing any significant change). Overall males predomi-
nated over females (M: F ratio) Year wise distribution of
cases show male were more frequently affected as com-
pared to females. Month-wise and week wise distribution
of positive cases in all the three years (fig 1) have shown a
peak in the 2nd and 3rd week of October. Age-wise distribu-
tion of IgM positive cases in all three years (fig. 2) clearly
indicates that older age groups (>10 years) were more
commonly affected than the age group ≤ 10 years (p <
0.001). Age group most commonly affected in all three
years being 21–30 yrs. Clinically, percentages of dengue
hemorrhagic fever (DHF) in confirmed dengue cases has
shown a linear trend and were significantly more in 2005
than in the years 2004 and 2003 (p < 0.001).(Table 1)
Eighty five serum samples were processed for virus isola-
tion, followed by IFA for serotype identification (Table 2).
Samples received in the year 2004 and 2005 were also
subjected to multiplex RT-PCR. In the year 2003, only cul-
ture confirmed cases were further subjected to RT-PCR for
re-confirmation of the serotype. All four serotypes of den-
gue -1, 2, 3, 4 were co-circulating in 2003[4]. In 2004 only
four samples were received for virus isolation, two were
positive for dengue virus by culture and RT-PCR and both
were identified as dengue-1. In 2005, predominant sero-
type obtained was dengue-3 and apart from dengue-3
only dengue-1 was the other serotype seen. In 2005, five
cases were culture positive and all were identified as den-
gue-3 by Indirect immunofluorescence assay (IFA) and all
five patients had DHF. While by RT-PCR dengue virus
RNA was detected in 17 samples of which 14 were den-
gue-3, 1 DEN1 and 2 samples had dual infection with
dengue-1 and dengue-3 serotypes.
Discussion
Dengue is emerging as a major public health problem in
India. Since the first epidemic in Kolkata during 1963–64
many places in India have been experiencing dengue
infection [6]. One of the largest outbreaks in North India
occurred in Delhi and adjoining areas in the year 1996.
The 1996 epidemic was mainly due to dengue-2 virus
[2,3]. Following this in the post epidemic period, 1997,
dengue-1 virus activity was seen in Delhi [7]. Thereafter,
in the year 2003 another outbreak occurred in Delhi and
all four dengue virus serotypes were found to be co-circu-
lating [4,5]. However, dengue-3 was reported to predom-
inate in certain parts of North India in 2003[8].
In the following year (2004 and 2005) though no out-
break occurred in Delhi, definitely higher number of cases
than usual were referred to our laboratory for testing. The
seasonality of transmission of dengue with increased
activity in the post monsoon season was seen in the
present study; in accordance with the reported patterns of
dengue transmission [9]. Even in the post-epidemic
period (2004& 2005) increased dengue virus activity was
seen in post monsoon period September to November
with peak in the second and third week of October. Simi-
lar observation was seen in the year 1997 following 1996
epidemic [7]. These findings indicate that during epi-
demic and non-epidemic years dengue infections are
mostly seen in post monsoon season hence preventive
measures should be in full swing at the very onset of the
monsoon.
Age wise distribution of the seropositive cases in all 3
years shows that statistically significant number of cases
were in older age group (>10 yrs) as compared to the
younger age group (≤ 10 yrs) (p value = <0.001). This
observation is quite in accordance with our previous
reported study [4] and with other studies from Delhi [10].
However many studies from South India [11] found chil-
dren more susceptible to infection than the adults.
The predominant dengue virus serotype seen in the year
1997, following dengue-2 epidemic in 1996 was dengue-
1[7]. In this study in the year 2004, dengue-1 was found
to be circulating following 2003 outbreak, which involved
all four serotypes. In the year 2005, however, in majority
of cases dengue-3 was identified. dengue-2 and dengue-4
were not identified in 2005 indicating that dengue-3
seems to have replaced dengue-2 and 4 to establish itself
as the predominant strain in Delhi.
Over the past two decades, dengue-3 has caused unex-
pected epidemics of DHF in Srilanka, East Africa and Latin
America [12]. Emergence of dengue-3 has also been
reported in 2003 as well as 2004 from certain parts in
North India [8,13,14].
The present study reports the emergence of dengue-3 as
the predominant serotype in Delhi in the year 2005. Fur-
ther studies regarding the molecular characterization of
these dengue-3 viruses are underway. Epidemiology of
dengue infection in Delhi is rapidly changing face, with
frequency of outbreaks increasing, even as dengue estab-
lishes itself as endemic disease. The need of the hour is to
characterize the circulating serotypes of dengue virus in
our community and understand the evolutionary proc-Virology Journal 2006, 3:92 http://www.virologyj.com/content/3/1/92
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esses influencing the dengue virus, as this is expected to
impact on vaccination strategies for future.
Conclusion
The year 2003 witnessed an outbreak after 1996 in Delhi.
All four dengue serotypes were seen circulating but in
2005 complete pre dominance of dengue-3 was seen. The
demographic picture of serologically confirmed cases in
all three years remained almost the same with predomi-
nant age group involved as 21–30 years and maximum
cases being seen in the post monsoon season of October.
Methods
Specimens
A total number of 1820 (Table 1) acute phase clotted
blood samples collected from clinically suspected cases of
dengue virus infection, coming to the various outpatient
departments, emergency services and admitted patients at
AIIMS, were tested for dengue specific IgM antibodies
when the duration of fever was ≥5 days. When the dura-
tion of fever <5 days, acute phase clotted blood samples
(n = 85) were collected on ice and transported to the virol-
ogy laboratory in cold condition for viral isolation and
reverse transcriptase polymerase chain reaction (RT-PCR).
The Ethics committee of the institution approved this
study.
Virus isolation
Virus isolation was carried out in the C6/36 clone of Aedes
albopictus cell lines as described by Broor et al (1997)[2].
Briefly, one in ten dilution of each serum sample (dura-
tion of fever <5 days) was inoculated in duplicate on a
confluent monolayer of C6/36 cell line and were incu-
bated at 25°C for 10 days. On the 10th day, one tube was
frozen at -70°C and cells from the other tube were har-
vested and cell spots were made on Teflon coated slides
from each sample. Uninfected clone of Aedes albopictus cell
line was used as negative control and cell lines infected
Table 1: Demographic Profile of Serologically confirmed cases
2003 2004 2005
IgM positive Cases 456 95 260
DHF Cases 47(10.3%)* 10(10.5%)* 62(23.8%)*
Male: Female ratio 2.3:1 1.7:1 1.9:1
≤ 10 Years 113 21 61
> 10 Years 343* 74* 199*
* p-value significant < 0.001
Weekly distribution of IgM positive dengue cases of all three years Figure 1
Weekly distribution of IgM positive dengue cases of all three years.
0
10
20
30
40
50
60
70
80
90
100
B
e
f
o
r
e
 
S
e
p
t
1
-
7
 
S
e
p
8
-
1
4
 
S
e
p
1
5
-
2
1
 
S
e
p
2
2
-
3
0
 
S
e
p
1
-
7
 
O
c
t
8
-
1
4
 
O
c
t
1
5
-
2
1
 
O
c
t
2
2
-
2
8
 
O
c
t
2
9
 
O
c
t
-
4
 
N
o
v
5
-
1
1
 
N
o
v
1
2
-
1
8
 
N
o
v
1
9
-
2
5
 
N
o
v
2
6
 
N
o
v
 
&
 
L
a
t
e
r
N
o
.
 
o
f
 
C
a
s
e
s
2003
2004
2005Virology Journal 2006, 3:92 http://www.virologyj.com/content/3/1/92
Page 4 of 5
(page number not for citation purposes)
with dengue virus 1 to 4 (Obtained from the National
Institute of Virology, Pune, India) were included as posi-
tive controls in each run. IFA was performed on these
spots using monoclonal antibodies to dengue 1–4 (pro-
vided by Dr. D.J. Gubler, then at CDC, Atlanta, during the
1996 outbreak). If IFA was negative for dengue viruses on
first passage, a blinded second passage was made and cells
were again harvested on 10th day for IFA. If the IFA was
still negative for dengue viruses, then the sample was
declared negative for virus isolation [15].
IgM antibody capture enzyme linked immunosorbent 
assay (MAC-ELISA)
Serum sample (duration of fever ≥5 days) were screened
for the presence of IgM antibodies using IgM capture
ELISA PanBio, Australia) following the manufactures pro-
tocol. OD was measured at 450 nm using an ELISA reader
(Labsystems Multiskan Plus Finland).
Dengue specific reverse transcriptase polymerase chain 
reaction (RT-PCR)
Dengue viral RNA was isolated from the serum samples
using the QIA amp viral RNA mini kit (Qiagen, Germany)
as per manufactures protocol. The RT-PCR assay
employed in this study could distinguish the 4 dengue
serotypes by the size of the products as described by Lan-
ciotti et.al [16]. This includes a step of RT-PCR using a
highly conserved primer pair, D1 (forward) and D2
(reverse) and a step of second-round PCR using the
Age wise distribution of IgM positive dengue cases of all three years Figure 2
Age wise distribution of IgM positive dengue cases of all three years.
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Table 2: Dengue Serotype identified over Years
2003 2004 2005
Total Cases(n) duration of fever <5 days 42 4 39
Culture Positive 8 2 5
RT PCR Positive 8(only on culture +ve) 2 17
Dengue Serotype By IFA & RT-PCR 2 dengue-1
2 dengue-2
3 dengue-3
1 dengue-4
2 dengue-1 1 dengue-1
14 dengue-3
2 dengue-1 plus
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primer D1 and 4 serotype-specific primers, TS1, TS2, TS3
and TS4.
The expected size of the RT-PCR products is 511 bp (D1
and D2) (external PCR product) and 482-bp (D1 and TS1
for dengue-1), 119-bp (D1 and TS2 for dengue-2), 290 bp
(D1 and TS3 for dengue-3) and 392-bp (D1 and TS4 for
dengue-4). The products were electrophoresed through
2% agarose gel, stained with ethidium bromide and
examined under ultraviolet light using a digital gel docu-
mentation system.
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